Biotech

All Articles

Neurocrine's quote to spare schizophrenia prospect stops working

.Neurocrine Biosciences' mental illness course pivot has actually fallen short. The biotech was actu...

Sanofi pays out $110M upfront for late-stage radioligand treatment

.Sanofi has actually made a late entrance to the radioligand event, paying out 100 million euros ($ ...

F 2G raises $100M for second attempt to receive new antifungal to market

.After F2G's initial attempt to receive a new class of antifungal to market was actually hindered by...

Moderna targets $1.1 B in R&ampD costs slices, drops 5 courses in the middle of success tensions

.Moderna has actually promised to cut R&ampD investing through $1.1 billion by 2027. The choice to r...

Sanofi's $80M bet on Pivot dystrophy medication finishes in period 3 go belly up

.Simply four months after Sanofi wager $80 thousand in beforehand cash money on Fulcrum Therapies' l...

Oncternal equity sinks 60% in the middle of layoffs, trial discontinuations

.Cancer provider Oncternal Therapeutics is actually folding all its professional tests as well as la...

Roche is carrying out chances that its own injectable weight problems prospect could ultimately show 25% weight loss in late-stage test

.Roche is actually storing out hopes that its injectable obesity prospect might inevitably show 25% ...

Novo Nordisk hails 'outstanding' effective weight loss result for dual-acting oral drug in very early test

.Novo Nordisk has actually lifted the top on a period 1 test of its oral amylin and also GLP-1 recep...

AbbVie takes legal action against BeiGene over blood cancer medication trade secrets

.Merely a few brief full weeks after gaining an FDA Fast Track tag for its investigational BTK degra...

Lilly supplies one-two punch along with second tranche of favorable records on every week blood insulin candidate

.Soon after a favorable information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based fir...